🇺🇸 FDA
Patent

US 11628146

Estrogen receptor ligand treatment for neurodegenerative diseases

granted A61KA61K2300/00A61K31/05

Quick answer

US patent 11628146 (Estrogen receptor ligand treatment for neurodegenerative diseases) held by The Regents of the University of California expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2300/00, A61K31/05, A61K31/137, A61K31/225